An update for endometriosis management: a position statement - 02/02/24

Doi : 10.1016/j.jeud.2024.100062 
Felice Petraglia a, , Silvia Vannuccini a, Pietro Santulli b, c, Louis Marcellin b, c, Charles Chapron b, c
a Obstetrics and Gynecology, Department of Experimental, Clinical and Biomedical Sciences "Mario Serio", University of Florence, Careggi University Hospital, Florence, Italy 
b Université Paris-Cité, Faculté de Santé, Faculté de Médicine Paris Centre, Paris, France 
c Assistance Publique – Hôpitaux de Paris (AP-HP), Hôpital Universitaire Paris Centre (HUPC), Centre Hospitalier Universitaire (CHU) Cochin, Department of Gynecology Obstetrics II and Reproductive Medicine, Paris, France 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Highlights

A diagnosis of endometriosis should be already suspected among adolescents and young women with severe dysmenorrhea.
There is no longer need to perform laparoscopy just to confirm and stage endometriosis.
Endometriosis can be accurately diagnosed non-invasively by clinical presentation and imaging.
The choice of endometriosis treatment is based on lesions and patient’s characteristics.
Patients’ age, previous response and tolerance to medical therapies and reproductive plans are factors to consider for the management of endometriosis.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Endometriosis is a complex disease and still many areas of uncertainty exist on the clinical management, from the diagnosis to the treatment. The modern diagnostic workup should include the family history (including genetic and epigenetic factors), the clinical presentation, an accurate gynecological examination and an imaging evaluation (transvaginal ultrasound and/or magnetic resonance) performed by expert practitioners. Laparoscopy must no longer be performed with the sole purpose of diagnosing endometriosis. Furthermore, a diagnosis of endometriosis should be already suspected among adolescents and young women with severe dysmenorrhea, interfering with daily activities and not responding to analgesic drugs.

For patients without immediate desire of pregnancy, hormonal drugs are first line choices for treating endometriosis-related pain, aiming to reduce menstruation frequency and even abolishing any bleeding. Progestins or continuous combined oral contraceptives are used for long term treatment and should be prescribed as first-line option. In case of failure or intolerance, GnRH analogs or more recently oral GnRH antagonists may be proposed (with or without an add-back therapy). Surgery remains an important treatment option, but it should be performed at the right time, as a single operation, preferentially in referral centers by dedicated multidisciplinary teams, in order to avoid recurrences and/or repetitive surgery. Assisted reproductive technology (ART) is an option for treating endometriosis-related infertility either as first line approach, or after surgical approach. Fertility preservation can be discussed at the moment of diagnosis of endometriosis or before performing surgery when indicated.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Endometriosis, Pain, Infertility, Diagnosis, Transvaginal ultrasound, MRI, Progestins, Combined oral contraceptives, GnRHa, Oral GnRH antagonists, Surgery, Assisted reproduction, oocyte cryopreservation


Mappa


© 2024  Society of Endometriosis and Uterine Disorders (SEUD). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 6

Articolo 100062- Giugno 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Contents
| Articolo seguente Articolo seguente
  • Hyaluronic acid in the prevention of adhesions after gynecological surgery: systematic review and meta-analysis
  • Leila Adamyan, Laura Pivazyan, Ekaterina Krylova, Kristina Kurbatova, Veronika Tarlakyan, Assia Stepanian

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.